Profile picture

Professor Silvio Inzucchi

New Haven (United States of America)
Follow
Logo ESC

Contributor content

Interactive discussion: what are the implications of SGLT2 inhibition for CV risk reduction in a multi-risk patient population?
Presentation
Interactive discussion: what are the implications of SGLT2 inhibition for CV risk reduction in a multi-risk patient population?
See more
SGLT-2 inhibitors in the management of CVD and T2DM: brief update on results of the EMPA-REG OUTCOME trial.
Presentation
SGLT-2 inhibitors in the management of CVD and T2DM: brief update on results of the EMPA-REG OUTCOME trial.
See more
SGLT-2 inhibitors in T2DM management: current position & future promise.
Presentation
SGLT-2 inhibitors in T2DM management: current position & future promise.
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources